Inspira Technologies
Inspira Technologies is a NASDAQ-listed medical device company that has pivoted into additive manufacturing electronics (AME) and quantum computing connectivity through the acquisition of Nano Dimension's AME and Fabrica product lines.
- CEO / Founder
- Dagi Ben-Noon
- Team Size
- 11-50
- Stage
- Public
- Total Funding
- $8.3M
- Latest Round
- Post-IPO
- Key Investors
- YA II PN, Ltd.
Technology & Products
Key Products
INSPIRA ART100 (FDA 510(k)-cleared blood oxygenation system for cardiopulmonary bypass); INSPIRA ART500 (adaptive blood oxygenation system for awake patients); HYLA blood sensor (continuous real-time blood monitoring); AME Platform (additively manufactured electronics 3D printing system acquired from Nano Dimension); Fabrica product line (micro 3D printing); VORTX orbiting blood oxygenation technology; Cryogenic interconnects for quantum computing
Technological Advantage
Acquired Nano Dimension's AME platform (multi-material 3D printing of electronics) and Fabrica micro-AM line for $12.5M; holds FDA 510(k) clearance for ART100; growing patent portfolio including VORTX, Dual Lumen Cannula, Initiation Module, Cannula Fixation Device; team includes former Nano Dimension executives who built the AME technology.
Differentiation
Value Proposition
Originally focused on augmented respiration technology (INSPIRA ART500) to reduce reliance on mechanical ventilators, Inspira has expanded into additive manufacturing electronics (AME) — multi-material 3D printing of electronic layers — and quantum computing cryogenic interconnects, leveraging acquired IP from Nano Dimension.
How They Differentiate
Inspira differentiates through its unique dual identity: it is both a regulated medical device company with FDA-cleared products AND an AME platform provider with Nano Dimension's heritage. The AME technology enables multi-material 3D printing of electronics layers for quantum computing and defense applications — a niche that combines additive manufacturing with high-reliability electronics.
Market & Competition
Target Customers
Hospitals and ICUs (medical devices); defense and aerospace entities (AME systems for quantum computing connectivity); research universities (AME systems); quantum computing companies (cryogenic interconnects)
Industry Verticals
Medical Devices / Respiratory Care; Additive Manufacturing / 3D Printed Electronics; Quantum Computing; Defense
Competitors
Optomec Inc. (USA) — aerosol jet printing for electronics; BotFactory Inc. (USA) — 3D printed circuit boards; nScrypt Inc. (USA) — micro-dispensing for electronics
Growth & Milestones
Growth Metrics
Market cap ~$20M (April 2026); $49.5M in binding purchase orders reaffirmed for 2026; $390K purchase order from APAC university (April 2026); $2.1M cash and equivalents (June 2025)
Major Milestones
2018: Company founded; Jul 2021: IPO on NASDAQ (IINN); 2023: FDA 510(k) clearance for INSPIRA ART100 (K232788); Dec 2025: $1.8M registered direct offering + $25M SEPA with YA II PN; Apr 2026: Acquired Nano Dimension's AME platform and Fabrica product lines for up to $12.5M; Apr 2026: Delivered AME system to Tier-1 US defense entity; Apr 2026: Signed JDA with Qarakal for quantum cryogenic interconnects
Notable Customers
Tier-1 US defense entity (AME system deployment for quantum computing); Premier APAC research university ($390K purchase order); US hospitals (ART100)